Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,260 | 42,849 | 43,049 | 43,269 | 66,196 |
| Marketable Securities | 9,998 | 9,868 | 24,688 | 40,157 | 21,175 |
| Receivables | 8,947 | 8,305 | 17,377 | 9,927 | 14,033 |
| Other current assets | 0 | 0 | 0 | 41,999 | 0 |
| TOTAL | $60,891 | $62,890 | $86,938 | $137,013 | $103,427 |
| Non-Current Assets | |||||
| PPE Net | 678 | 695 | 736 | 642 | 689 |
| Intangibles | 70,855 | 72,400 | 73,928 | 0 | 0 |
| Other Non-Current Assets | 11,984 | 15,298 | 10,725 | 1,327 | 1,402 |
| TOTAL | $83,517 | $88,393 | $85,389 | $1,969 | $2,091 |
| Total Assets | $144,408 | $151,283 | $172,327 | $138,982 | $105,518 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 37,700 | N/A | N/A |
| Accounts payable and accrued liabilities | 20,452 | 22,785 | 28,403 | 13,080 | 10,510 |
| Other current liabilities | 9,401 | 6,541 | 7,074 | 8,201 | 7,286 |
| TOTAL | $30,449 | $29,909 | $73,720 | $21,714 | $18,252 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,328 | 42,998 | 5,066 | 43,874 | 12,709 |
| Other Non-Current Liabilities | 23,153 | 29,558 | 31,677 | 5,924 | 6,058 |
| TOTAL | $81,481 | $72,556 | $36,743 | $49,798 | $18,767 |
| Total Liabilities | $111,930 | $102,465 | $110,463 | $71,512 | $37,019 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,618 | 41,854 | 43,426 | 36,218 | 33,933 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -436,325 | -416,400 | -399,778 | -339,468 | -325,423 |
| Other shareholders' equity | 438 | 158 | -26 | -203 | -208 |
| TOTAL | $32,478 | $48,818 | $61,864 | $67,470 | $68,499 |
| Total Liabilities And Equity | $144,408 | $151,283 | $172,327 | $138,982 | $105,518 |